GluN3A knockout mouse: Alternative model for Alzheimer's neurodegeneration

In recent debate over the FDA's approval of the Alzheimer's drug aducanumab, we've heard a lot about the "amyloid hypothesis." In that context, it's refreshing to learn about a model of Alzheimer's neurodegeneration that doesn't start with the pathogenic proteins amyloid or Tau.

source https://medicalxpress.com/news/2021-06-glun3a-knockout-mouse-alternative-alzheimer.html